Title: The molecular mechanisms of nutrient- and stress-dependent mTORC1 regulation mediated by human Sestrin2. Project Summary The mTOR complex 1 (mTORC1) is an important nutrient sensor whose chronic activation by overnutrition can provoke diverse metabolic pathologies such as insulin resistance and type II diabetes. Most pharmacological inhibitors of mTORC1, however, non-specifically suppress mTORC2?another mTOR complex that is critical for mediating insulin signal transduction?and thus inappropriate for diabetes treatment. Sestrins (Sesns) are recently identified mTORC1 suppressors. mTORC1-inhibitory function of Sesns attenuates development of most hypernutrition- and obesity- associated metabolic pathologies. Importantly, Sesns does not inhibit mTORC2 and rather upregulates its activity by suppressing mTORC1. Correspondingly, transgenic Sesn overexpression was highly effective in protecting liver from chronic mTORC1 activation, development of insulin resistance and progression of diabetic pathologies. These results suggest that Sesns and their downstream signaling pathway may have a therapeutic potential as a drug target toward the obesity-associated diseases. Recently, a number of studies by our labs and others have clarified the molecular targets of Sesns, which led to a clearer understanding of how Sesns inhibit mTORC1. As a result of extensive genetics and cell biology studies, a clear epistatic relationship between GATOR2, GATOR1, Rag GTPases and mTORC1 was established. Furthermore, a couple of recent papers also suggested that an amino acid leucine can bind to Sesns and modulates their activities. Despite its physiological significance, the biochemical and molecular basis by which these proteins interact with and signal to each other is still completely unknown. Without an understanding of the molecular level mechanism, it is nearly impossible to rationally design chemical probes to modulate this signaling cascade. As a part of this effort, we have recently determined the first crystal structure of human Sestrin2 (hSesn2), and are currently planning to use it as a starting platform for understanding the Sesn-dependent signal transduction pathway. Our long-term goal is to define the biochemical and structural properties of each signaling component within the Sesn-dependent signaling cascade and to reveal druggable structural motifs that are critical for functionality of this signaling pathway. Using a combination of X-ray crystallography, molecular electron microscopy (EM), cell biology and Drosophila/mouse genetics experiments, we will elucidate the structural, biochemical and cell-biological role of hSesn2 and its signaling intermediates?GATOR1 and GATOR2?in mTORC1 suppression. The molecular mechanisms and structural motifs identified from these studies are expected to reveal many new drug targets for future development of mTORC1-modulating pharmaceutical agents, which will be clinically significant for reducing the progression of diverse metabolic pathologies caused by hypernutrition and obesity.

Public Health Relevance

Constant exposure to a high nutrient diet and increased insulin levels often leads to type II diabetes and non-alcoholic fatty liver diseases. The mechanistic target of rapamycin complex 1 (mTORC1) plays a central role in this regulation and therefore has long been considered as an attractive target for type II diabetes. In this proposed research, we particularly focus on understanding the nutrient- and stress-dependent mTORC1 regulation pathway mediated by Sestrins, a stress- inducible protein family, using multi-directional approaches including x-ray crystallography, single particle cryo-electron microscopy and cell biology. Structural and biological studies of Sestrin and signaling intermediates of mTORC1, GATOR1 and GATOR2, will not only reveal the fundamental mechanism of how nutrient and stress can modulate mTORC1, but also provide the molecular platform to develop knowledge-based anti-diabetic medicines by targeting this pathway.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK111465-05
Application #
9996571
Study Section
Molecular and Integrative Signal Transduction Study Section (MIST)
Program Officer
Silva, Corinne M
Project Start
2016-09-19
Project End
2021-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Biochemistry
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Yoon, Jungmin; Kim, Seung Joong; An, Sojin et al. (2018) Integrative Structural Investigation on the Architecture of Human Importin4_Histone H3/H4_Asf1a Complex and Its Histone H3 Tail Binding. J Mol Biol 430:822-841
An, Sojin; Koldewey, Philipp; Chik, Jennifer et al. (2018) Mis16 Switches Function from a Histone H4 Chaperone to a CENP-ACnp1-Specific Assembly Factor through Eic1 Interaction. Structure 26:960-971.e4
An, Sojin; Yoon, Jungmin; Kim, Hanseong et al. (2017) Structure-based nuclear import mechanism of histones H3 and H4 mediated by Kap123. Elife 6:
Vitvitsky, Victor; Yadav, Pramod K; An, Sojin et al. (2017) Structural and Mechanistic Insights into Hemoglobin-catalyzed Hydrogen Sulfide Oxidation and the Fate of Polysulfide Products. J Biol Chem 292:5584-5592